Roxann Beckner Email & Phone Number

Bedminster, New Jersey, United States

Hired to build the commercial medical sales team for entire United States. Direct Reports: 10. Budget: $1M.✅ Call Points: Healthcare Professionals, Long-term Care Facilities, Retail Pharmacies, and GPOs✅ Territory: U.S. Marketplace✅ Products/Disease States: FLORASTOR (probiotic), Gut Health➡️ Sales Strategy and Execution:📌 Drove transition from Long Term Care (LTC) to Health Care Professionals (HCP) focus, surpassing annual sales goals by 150% in 2021 and 165% in 2022.📌 Collaborated with IQVIA to understand market competition and market share and generate target list of HCP accounts for each territory, generating Average Weekly Recommendations (AWR) as part of a Management by Objectives (MBO) initiative.📌 Implemented a Sales Incentive Program, set daily call average MBOs, and forecasted sales goals, fostering a performance-driven culture within the Medical Sales team.📌 Spearheaded the H2 2023 launch preparations for two newly approved patient types, orchestrating training, role-playing, and certifications to enhance market responsiveness.➡️ Process Improvement:📌 Led the creation of new process management for existing rebate contracts and signed 3 new major rebate contracts at $1M per year each with GeriMed, Pharmerica, and Guardian.📌 Orchestrated the development of HCP marketing materials and worked with KOL’s to obtain permission to utilize meta-analysis data.📌 Initiated medical conference participation and exhibition to drive new HCP strategy—6 in '22, 14 in '23, and 18 planned for '24.➡️ Team Leadership and Development:📌 Orchestrated comprehensive recruitment, hiring, and training programs, successfully establishing a high-performing US salesforce from the ground up—Secured approval for US expansion in 2024.📌 Engaged in rigorous weekly and quarterly performance evaluations through field visits, coaching reports, and individual/team virtual meetings, ensuring continuous learning and performance enhancement.

Parsippany, New Jersey, United States

Selected to address organizational challenges and drive achievement of growth goals and objectives. Direct Reports: 10 over 2 sales forces. Budget: $2M.✅ Call Points: Hospitals, Critical Care Centers, Microbiology Labs, Pharmacies, Infusion Centers (physician & hospital owned), Physician Offices, Specialty Pharmacies, including HUB services✅ Institutions (Sampling): Advent Health, BayCare, Tampa General, Moffitt Cancer Center, Tenet Hospitals, Florida Cancer Specialists✅ Territory: Florida, Georgia, Alabama, Louisianna✅ Products/Disease States: BAXDELA (IV/Oral, Bacterial Infections), VABOMERE (IV, Rare Multi-Drug Resistant Bacteria), ORBACTIV (IV, Bacterial Infections)➡️ Sales and Product Performance:📌 Spearheaded seamless reverse merger amidst leadership and sales force reshuffles and piloted 4 team realignment initiatives, surpassing sales goals across multiple drug markets.📌 Launched BAXDELA with the 1st RX in the nation in 2018, achieving 713% to-goal in Q2 2019 📌 Inherited VABOMERE and ORBACTIV post-acquisition; steered the relaunch strategy, surpassing sales goals in 2018 & 2019.📌 Amplified E-Testing across numerous institutions leading to VABOMERE being chosen as the preferred KPC/CRE ABX by prominent health systems.📌 Secured 3 large infusion suites, marking the first contracts in the region 4 years post-original launch.➡️ Team Building and Leadership:📌 Pioneered transition to remote selling prior to the Covid-19 onset in a startup setting, optimizing the use of limited resources. 📌 Achieved a Top 5% ranking in 2019; propelled 2 territories to win the prestigious CEO Award-Orlando (2018) and Miami (2019).➡️ Strategic Relationship Management:📌 Fostered relationships with key medical professionals; secured specialty pharmacy for outplacement RX and enhanced retail pharmacy stocking at Advent Health.📌 Resolved ORBACTIV reimbursement issues, secured new contracts, and reduced patient co-payments by identifying 1-dose candidates.

Lexington, Massachusetts, United States

Recruited to define and drive business development strategy. Direct Reports: 10. Budget: $2.5M (including speaker programs). Awards: National Center of Excellence Award 2014, MVP 2007/2011.✅ Call Points: Hospitals, Specialty Care/Long Term Care, Infusion Centers (physician & hospital owned), Home Infusion Providers✅ Institutions (Sampling): Advent Health, HCA Hospitals, Tenet Health✅ Territory: East Florida and Puerto Rico✅ Products/Disease States: CUBICIN, DIFICID, SIVEXTRO, ZERBAXA (Infectious Disease), ENTEREG (Surgery )➡️ Product Launch:📌 Launched 3 products: ✔️ SIVEXTRO: Built internal network to provide bedside delivery at discharge; improved patient satisfaction scorecard and recreated bedside delivery model through partnership with Specialty Walgreens.✔️ ZERBAXA: Achieved formulary addition at San Juan VA as #1 account 3-months into launch and Advent Health Orlando immediately.✔️ CUBICIN: Generated $63M in sales with an outpatient/inpatient split of 55%/45%—Ranked #2 of 25 regions➡️ Market Penetration:📌 Awarded hospital formulary approval for Dificid—one of only 2 territories in the nation— generating $400K in sales within 6 months post-launch. 📌 Developed Puerto Rico into an $8M territory—previously struggling at $355K in sales.